In the last decade, it has become clear that fibulin-3 appears to play a dual role in cancer depending on different cancer-cell contexts, promoting tumorigenesis in some cancers [10–13] or having anti-tumor effects in others [58]. This evidence concerns the gene EFEMP1 and cancer.